Use of Lipids in Neonates Requiring Parenteral Nutrition.
fish oil
inflammation
lipids
neonate: oxidative stress
omega-3
omega-6
parenteral nutrition
pediatric
soybean oil
Journal
JPEN. Journal of parenteral and enteral nutrition
ISSN: 1941-2444
Titre abrégé: JPEN J Parenter Enteral Nutr
Pays: United States
ID NLM: 7804134
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
09
07
2019
revised:
19
11
2019
accepted:
20
11
2019
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
4
3
2021
Statut:
ppublish
Résumé
Neonates have limited antioxidative capacity and are at increased risk of infection and inflammation-a situation that is exacerbated in preterm neonates. Together, oxidative stress and inflammation are implicated in many serious conditions affecting neonates, such as bronchopulmonary dysplasia and periventricular leukomalacia. Neonates requiring parenteral nutrition have certain nutritional requirements. For example, very long-chain ω-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are regarded as conditionally essential with critical roles during early retinal and brain development, and may also have other benefits such as anti-inflammatory effects. Because of these factors, the choice of lipid emulsion used as part of parenteral nutrition support may influence clinical outcomes in neonates. There are concerns that lipid emulsions based purely on soybean oil may increase lipid peroxidation, oxidative stress, and inflammation because of their high ω-6 PUFA and low ω-3 PUFA concentrations. Composite fish-oil containing lipid emulsions may provide advantages for neonates owing to their high DHA and EPA content and high antioxidant (α-tocopherol) levels. Here, we discuss clinical trials of lipid emulsions in preterm and term neonatal populations, with a particular emphasis on markers of oxidative stress and DHA and EPA levels. Olive oil/soybean oil lipid emulsions have shown few advantages in neonates over other lipid emulsions. However, compared with either pure soybean or soybean/olive-oil based emulsions, composite fish-oil containing lipid emulsions reduce oxidative stress/lipid peroxidation and also increase DHA and EPA levels. These advantages may translate into clinical benefits for neonates requiring parenteral nutrition.
Substances chimiques
Fat Emulsions, Intravenous
0
Fatty Acids, Omega-3
0
Fish Oils
0
Olive Oil
0
Soybean Oil
8001-22-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S45-S54Informations de copyright
© 2020 American Society for Parenteral and Enteral Nutrition.
Références
Martindale RG, Berlana D, Boullata J, et al. Summary of proceedings and consensus statements from the international summit ‘Lipids in Parenteral Nutrition’. JPEN J Parenter Enteral Nutr. 2020.
Lapillonne A, Fidler Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr. 2018;37(6 Pt B):2324-2336.
Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41(Suppl 2):S1-S87.
Calder PC, Adolph M, Deutz NE, et al. Lipids in the intensive care unit: recommendations from the ESPEN Expert Group. Clin Nutr. 2018;37(1):1-18.
Raman M, Almutairdi A, Mulesa L, Alberda C, Beattie C, Gramlich L. Parenteral nutrition and lipids. Nutrients. 2017;9(4):388.
Deckelbaum RJ. Intravenous lipid emulsions in pediatrics: time for a change? J Pediatr Gastroenterol Nutr. 2003;37(2):112-114.
Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr. 2006;30(4):351-367.
Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc. 2006;65(3):264-277.
Deshpande G, Simmer K, Deshmukh M, Mori TA, Croft KD, Kristensen J. Fish oil (SMOFlipid) and olive oil lipid (ClinOleic) in very preterm neonates. J Pediatr Gastroenterol Nutr. 2014;58(2):177-182.
Cai W, Calder PC, Cury-Boaventura MF, De Waele E, Jakubowski J, Zaloga G. Biological and clinical aspects of an olive oil-based lipid emulsion-a review. Nutrients. 2018;10(6):776.
Deshpande GC, Simmer K, Mori T, Croft K. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (<28 weeks’ gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr. 2009;49(5):619-625.
Grimm H, Kraus A. Immunonutrition-supplementary amino acids and fatty acids ameliorate immune deficiency in critically ill patients. Langenbecks Arch Surg. 2001;386(5):369-376.
Carlson SJ, Fallon EM, Kalish BT, Gura KM, Puder M. The role of the ω-3 fatty acid DHA in the human life cycle. JPEN J Parenter Enteral Nutr. 2013;37(1):15-22.
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469-484.
Miles EA, Calder PC. Fatty acids, lipid emulsions and the immune and inflammatory systems. World Rev Nutr Diet. 2015;112:17-30.
Sweeney B, Puri P, Reen DJ. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int. 2005;21(5):335-340
Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105-1115.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92-101.
Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2015;1851(4):397-413.
Embleton ND, Simmer K. Practice of parenteral nutrition in VLBW and ELBW infants. World Rev Nutr Diet. 2014;110:177-189.
Lapillonne A, Griffin IJ. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr. 2013;162(3 Suppl):S7-S16.
Vayalthrikkovil S, Bashir RA, Rabi Y, et al. Parenteral fish-oil lipid emulsions in the prevention of severe retinopathy of prematurity: a systematic review and meta-analysis. Am J Perinatol. 2017;34(7):705-715.
Park HW, Lee NM, Kim JH, Kim KS, Kim SN. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr. 2015;145(2):277-283.
Ozkan H, Koksal N, Dorum BA, et al. New generation fish oil and olive oil lipid on prevention of oxidative damage in preterm infants. Pediatr Int. 2019;61(4):388-392.
Varsila E, Hallman M, Andersson S. Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr. 1994;83(7):692-695.
Saugstad OD. Oxidative stress in the newborn-a 30-year perspective. Biol Neonate. 2005;88(3):228-236.
Lapillonne A, Eleni dit Trolli S, Kermorvant-Duchemin E. Postnatal docsahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. Neonatology. 2010;98(4):397-403.
Gobel Y, Koletzko B, Bohles HJ, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr. 2003;37(2):161-167.
Pitkanen OM, Luukkainen P, Andersson S. Attenuated lipid peroxidation in preterm infants during subsequent doses of intravenous lipids. Biol Neonate. 2004;85(3):184-187.
Webb AN, Hardy P, Peterkin M, et al. Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: a blinded randomized trial. Nutrition. 2008;24(11-12):1057-1064.
Roggero P, Mosca F, Giannì ML, et al. F2-isoprostanes and total radical-trapping antioxidant potential in preterm infants receiving parenteral lipid emulsions. Nutrition. 2010;26(5):551-555.
Köksal N, Kavurt AV, Cetinkaya M, Ozarda Y, Ozkan H. Comparison of lipid emulsions on antioxidant capacity in preterm infants receiving parenteral nutrition. Pediatr Int. 2011;53(4):562-566.
Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005;10(Suppl 1):S10-S23.
Musiek ES, Yin H, Milne GL, Morrow JD. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids. 2005;40(10):987-994.
Deshpande G, Rakshasbhuvankar A, Simmer K, Mori T, Croft K, Currie A. Efficacy and safety of a novel fish oil based emulsion (SMOFlipid®) compared with olive oil based lipid emulsion (ClinOleic®) in term and near-term (>34 weeks) surgical neonates-a randomised controlled trial. In: Pediatric Academic Societies (PAS) Annual Meeting; May, 4-7 2013; Washington DC, USA. Abstract 3838.626.
Tomsits E, Pataki M, Tölgyesi A, Fekete G, Rischak K, Szollár L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51(4):514-521.
Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010;64(9):940-947.
Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012;36(1 Suppl):81S-94S.
Vlaardingerbroek H, Vermeulen MJ, Carnielli VP, Vaz FM, van den Akker CH, van Goudoever JB. Growth and fatty acid profiles of VLBW infants receiving a multicomponent lipid emulsion from birth. J Pediatr Gastroenterol Nutr. 2014;58(4):417-427.
Skouroliakou M, Konstantinou D, Agakidis C, et al. Parenteral MCT/omega-3 polyunsaturated fatty acid-enriched intravenous fat emulsion is associated with cytokine and fatty acid profiles consistent with attenuated inflammatory response in preterm neonates: a randomized, double-blind clinical trial. Nutr Clin Pract. 2016;31(2):235-244.
Najm S, Löfqvist C, Hellgren G, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin Nutr ESPEN. 2017;20:17-23.
Unal S, Demirel N, Erol S, et al. Effects of two different lipid emulsions on morbidities and oxidant stress statuses in preterm infants: an observational study. J Matern Fetal Neonatal Med. 2018;31(7):850-856.
Yildizdas HY, Poyraz B, Atli G, et al. Effects of two different lipid emulsions on antioxidant status, lipid peroxidation and parenteral nutrition-related cholestasis in premature babies, a randomized-controlled study. Pediatr Neonatol. 2019;60(4):359-367.
Fink NH, Collins CT, Gibson RA, Makrides M, Penttila IA. Targeting inflammation in the preterm infant: the role of the omega-3 fatty acid docosahexaenoic acid. J Nutr Intermed Metab 2016;5:55-60.